Oneness Biotech Co., Ltd.
Research Oneness Biotech Co., Ltd. (4743.TWO) on Bullrun: market cap TWD 23.74B, P/E 380.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4743.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 23.74B
- P/E380.8
- Financial periodQ2 2026
- RevenueTWD 39.91M
- Net incomeTWD 249.71M
- Free cash flow-TWD 121.22M
- Gross margin51.9%
Valuation Snapshot
latest market cap is TWD 23.74B; P/E is 380.8.
Peer valuation comparison
Latest P/E is 380.77x versus a Healthcare sector median of 21.8x (1647.0% above).
Latest P/E is 380.77x versus a Taiwan median of 18.67x (1939.7% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 23.74B | 380.8 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Oneness Biotech Co., Ltd.
Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation and Organic Food segments. The company offers Fespixon which is a treatment of diabetic foot ulcer; and Bonvadis, a wound care medical device. It also develops FB825, which is in Phase II clinical trial for treating atopic dermatitis and allergic asthma;
ETFs that hold Oneness Biotech Co., Ltd.
US-listed ETFs
Oneness Biotech Co., Ltd. is held by 14 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares Core MSCI Total International Stock ETF (IXUS) | <0.01% | 0.07% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Vanguard ESG International Stock ETF (VSGX) | <0.01% | 0.10% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Oneness Biotech Co., Ltd.'s market cap?
Oneness Biotech Co., Ltd.'s market capitalization is TWD 23.74B.
What is Oneness Biotech Co., Ltd.'s P/E ratio?
Oneness Biotech Co., Ltd.'s price-to-earnings (P/E) ratio is 380.8.
What does Oneness Biotech Co., Ltd. do?
Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation and Organic Food segments. The company offers Fespixon which is a treatment of diabetic foot ulcer; and Bonvadis, a wound care medical device.